BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7836509)

  • 21. Induction of ovulation with purified urinary follicle-stimulating hormone in patients with polycystic ovarian syndrome.
    Garcea N; Campo S; Panetta V; Venneri M; Siccardi P; Dargenio R; De Tomasi F
    Am J Obstet Gynecol; 1985 Mar; 151(5):635-40. PubMed ID: 3919586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovulation induction using low-dose step-up rFSH in Vietnamese women with polycystic ovary syndrome.
    Lan VT; Norman RJ; Nhu GH; Tuan PH; Tuong HM
    Reprod Biomed Online; 2009 Apr; 18(4):516-21. PubMed ID: 19400993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of a gonadotrophin-releasing hormone agonist on treatment with low dose follicle stimulating hormone in polycystic ovary syndrome.
    Scheele F; Hompes PG; van der Meer M; Schoute E; Schoemaker J
    Hum Reprod; 1993 May; 8(5):699-704. PubMed ID: 8314962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of polycystic ovary disease with chronic low-dose follicle stimulating hormone: biochemical changes and ultrasound correlation.
    Seibel MM; Kamrava MM; McArdle C; Taymor ML
    Int J Fertil; 1984; 29(1):39-43. PubMed ID: 6146583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovulation induction with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression by gonadotropin releasing hormone agonist in polycystic ovary disease. A cross-over study.
    Fulghesu AM; Lanzone A; Guida C; Nicoletti MC; Rossi P; Le Donne M; Caruso A; Mancuso S
    J Reprod Med; 1992 Oct; 37(10):834-40. PubMed ID: 1479563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth of the dominant follicle is similar to normal in patients with gonadotrophin-stimulated polycystic ovary syndrome exhibiting monofollicular development during a decremental dose regimen.
    Schoot DC; Hop WC; Pache TD; de Jong FH; Fauser BC
    Acta Endocrinol (Copenh); 1993 Aug; 129(2):126-9. PubMed ID: 8372596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).
    Mitchell R; Buckler HM; Matson P; Lieberman B; Burger HG; Hilton B; Horne G; Dyson M; Robertson WR
    Hum Reprod; 1996 May; 11(5):962-7. PubMed ID: 8671371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aromatase inhibition reduces the dose of gonadotropin required for controlled ovarian hyperstimulation.
    Mitwally MF; Casper RF
    J Soc Gynecol Investig; 2004 Sep; 11(6):406-15. PubMed ID: 15350255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Follicle-stimulating hormone/luteinizing hormone ratio as an independent predictor of response to controlled ovarian stimulation.
    Kofinas JD; Elias RT
    Womens Health (Lond); 2014 Sep; 10(5):505-9. PubMed ID: 24807379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of endogenous gonadotropin release in the etiology of ovarian enlargement during purified urinary follicle-stimulating hormone therapy.
    Mizunuma H; Takagi T; Yamada K; Andoh K; Ibuki Y; Igarashi M
    Fertil Steril; 1991 Jan; 55(1):66-72. PubMed ID: 1898893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Octreotide, a somatostatin analogue, alters ovarian sensitivity to gonadotrophin stimulation as measured by the follicle stimulating hormone threshold in polycystic ovary syndrome.
    van der Meer M; de Boer JA; Hompes PG; Schoemaker J
    Hum Reprod; 1998 Jun; 13(6):1465-9. PubMed ID: 9688372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum FSH levels in women with polycystic ovary syndrome during ovulation induction using down-regulation and urofollitropin.
    Fridström M; Sjöblom P; Pousette A; Hillensjö T
    Eur J Endocrinol; 1997 May; 136(5):488-92. PubMed ID: 9186269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive Value of Elevated LH/FSH Ratio for Ovulation Induction in Patients with Polycystic Ovary Syndrome.
    Woo I; Tobler K; Khafagy A; Christianson MS; Yates M; Garcia J
    J Reprod Med; 2015; 60(11-12):495-500. PubMed ID: 26775457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequential low-dose step-up and step-down protocols with recombinant follicle-stimulating hormone in polycystic ovary syndrome: prospective comparison with step-down protocol.
    Casadei L; Puca F; Emidi E; Manicuti C; Madrigale A; Piccione E
    Arch Gynecol Obstet; 2012 Nov; 286(5):1291-7. PubMed ID: 22729136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome.
    Gill S; Taylor AE; Martin KA; Welt CK; Adams JM; Hall JE
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between follicle-stimulating hormone dose and level and its relevance for ovulation induction with adjuvant gonadotropin-releasing hormone-agonist treatment.
    Scheele F; Hompes PG; van der Meer M; Schoute E; Schoemaker J
    Fertil Steril; 1993 Oct; 60(4):620-5. PubMed ID: 8405514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose FSH stimulation in polycystic ovary syndrome: comparison of 3 FSH-preparations.
    Strowitzki T; Seehaus D; Korell M; Hepp H
    Exp Clin Endocrinol Diabetes; 1998; 106(5):435-9. PubMed ID: 9831312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant human follicle-stimulating hormone for ovulation induction in polycystic ovary syndrome: a prospective, randomized trial of two starting doses in a chronic low-dose step-up protocol.
    Balasch J; Fábregues F; Creus M; Casamitjana R; Puerto B; Vanrell JA
    J Assist Reprod Genet; 2000 Nov; 17(10):561-5. PubMed ID: 11209536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Importance of echographic and endocrine monitoring for the assessment of ovulation by follicle stimulating hormone in polycystic ovarian disease.
    Caruso A; Lanzone A; Fulghesu AM; Apa R; Guida C; Mancuso S
    Int J Gynaecol Obstet; 1989 Feb; 28(2):163-9. PubMed ID: 2563704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of ovulation with clomiphene citrate in women with polycystic ovary syndrome: the difference between responders and nonresponders.
    Polson DW; Kiddy DS; Mason HD; Franks S
    Fertil Steril; 1989 Jan; 51(1):30-4. PubMed ID: 2491994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.